| Literature DB >> 34616231 |
Abstract
BACKGROUND: Hyponatremia is a common electrolyte disorder in inpatients related to morbidity and mortality. In this study, we aimed to examine whether there is a relationship between the incidence of hyponatremia and the seasons among the patients hospitalized in our nephrology department.Entities:
Keywords: humidity; hyponatremia; renal failure; season; temperature
Year: 2021 PMID: 34616231 PMCID: PMC8451223 DOI: 10.5937/jomb0-30409
Source DB: PubMed Journal: J Med Biochem ISSN: 1452-8266 Impact factor: 3.402
Clinical and demographic data of the patients according to the seasons
Values for continuous variables are given as mean ± standard deviation; values for categorical variables are given as percentages. *: This p-value represents the significance of the 4x3 chi-square test. Abbreviations: BUN, blood urea nitrogen; BP, blood pressure; CKD, chronic kidney disease; AKI, acute kidney injury; CHF, congestive heart failure; CCB, Calcium channel blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; n (%), number and percentage of patients; a,b,c,d There is a significant difference between the parameters marked with the same letter (p<0.05).
| Autumn n = 109 | Winter n = 76 | Spring n = 89 | Summer n = 235 | ||
|---|---|---|---|---|---|
| Age (years) | 65.9±10.4 | 63.1±18.4 | 62.1±12.1 | 65.1±17.1 | 0.26 |
| Female/Male | 54/55 | 34/42 | 54/35 | 114/121 | 0.16 |
| Serum sodium (mmol/L) | 129.4.±5.9 | 130.5±5.2 | 129.7±4.1 | 129.5±4.3 | 0.37 |
| Creatinine (mmol/L) | 0.36±0.23 | 0.35±0.21 | 0.43±0.33 | 0.38±0.27 | 0.15 |
| BUN (mmol/L) | 22.6±13.9 | 21.9±12.7 | 22.5±13.1 | 22.3±14.4 | 0.99 |
| Systolic BP (mm Hg) | 125.4±29.8 | 119.1±26.1 | 119.2±29.3 | 125±28.1 | 0.18 |
| Diastolic BP (mm Hg) | 74.1±16.7 | 73.7±15.9 | 71.7±13.8 | 76.1±17.1 | 0.17 |
| Incidence of hyponatremia (%) | 28.7%a | 15.4%a,b | 20.4%c | 36.6%b,c | 0.001 |
| Existing disease, n (%) | |||||
| CKD | 83 (76.1%) | 58 (76.3%) | 56 (62.9%) | 161 (68.5%) | 0.12 |
| AKI | 25 (22.9%) | 15 (19.7%) | 29 (32.6%) | 66 (28.1%) | 0.21 |
| CHF | 24 (22.0%) | 15 (19.7%) | 10 (11.2%) | 48 (20.4%) | 0.22 |
| Nephrotic syndrome | 4 (3.7%) | 2 (2.6%) | 8 (9.0%) | 8 (3.4%) | 0.12 |
| Cirrhosis | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 3 (1.3%) | 0.32 |
| Diabetes mellitus | 59 (54.1%) | 38 (50%) | 35 (39.3%) | 96 (40.9%) | 0.07 |
| Hypertension | 74 (67.9%) | 45 (59.2%) | 45 (50.6%) | 129 (54.9%) | 0.06 |
| Medication use, n (%) | |||||
| ACEI/ARB | 31 (28.4%) | 19 (25%) | 16 (18.0%) | 77 (32.8%) | 0.06 |
| CCB | 34 (31.2%) | 23 (30.3%) | 15 (16.9%) | 71 (30.2%) | 0.08 |
| Thiazide | 16 (14.7%) | 12 (15.8%) | 11 (12.4%) | 31 (13.2%) | 0.91 |
| Furosemide | 32 (29.4%) | 22 (28.9%) | 18 (20.2%) | 58 (24.7%) | 0.44 |
| Spironolactone | 9 (8.3%) | 5 (6.6%) | 3 (3.4%) | 19 (8.1%) | 0.48 |
| Antidepressant | 15 (13.8%) | 12 (15.8%) | 12 (13.5%) | 29 (12.3%) | 0.89 |
| Volume status | |||||
| Hypovolemic | 51 (46.8%)a,b | 60 (78.9%)a,c | 71 (79.8%)b,d | 143 (60.9%)c,d | 0.001* |
| Euvolemic | 1 (0.9%) | 2 (2.6%) | 2 (2.2%) | 3 (1.3) | |
| Hypervolemic | 57 (52.3%)a,b | 14 (18.4%)a,c | 16 (18%)b,d | 89 (37.9%)c,d | |
Values of temperature and relative humidity according to the seasons
Plus-minus values are mean ± standard deviation. a,b,c,d There is a significant difference between the parameters marked with the same letter (p<0.05).
| Autumn | Winter | Spring | Summer | p-value | ||
|---|---|---|---|---|---|---|
| Temperature (°C) | Mean | 13.7±4.9a | 3.4±2.5a,b | 11.1±4.1b,c | 22.7±2.3a,c | 0.001 |
| Maximum | 34.1 | 16.6 | 26.1 | 39.2 | ||
| Minimum | -3.4 | -12.9 | -8.3 | 6.1 | ||
| Relative humidity (%) | Mean | 59.9±8.9a | 70.7±5.1a,b | 59.9±3.8b,c | 47.5±7.4a,c | 0.001 |
| Maximum | 96 | 97 | 94 | 81 | ||
| Minimum | 16 | 31 | 22 | 15 |
Figure 1Incidence of hyponatremia, percent (%) related to seasonal variability of temperature
Figure 2Incidence of hyponatremia (%) related to seasonal variability of relative humidity (%)
Variables associated with hyponatremia (<125 mmol/L)
Abbreviations: CI, confidence interval; CKD, chronic kidney disease; AKI, acute kidney injury; CHF, congestive heart failure; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, Calcium channel blocker.
| Odds ratio (95% CI) | |||
|---|---|---|---|
| Age | 1.0 (0.98–1.02) | 0.75 | |
| Gender | 0.91 (0.54–1.55) | 0.72 | |
| CKD | 2.69 (1.19–6.09) | 0.018 | |
| AKI | 1.91 (0.89–4.07) | 0.09 | |
| CHF | 0.89 (0.35–2.32) | 0.82 | |
| Nephrotic syndrome | 0.63 (0.15–2.59) | 0.52 | |
| Diabetes mellitus | 0.73 (0.41–1.30) | 0.29 | |
| ACEI/ARB | 1.19 (0.57–2.45) | 0.65 | |
| CCB | 0.51 (0.25–1.03) | 0.06 | |
| Thiazide | 1.18 (0.45–3.10) | 0.74 | |
| Furosemide | 1.51 (0.63–3.59) | 0.36 | |
| Spironolactone | 0.23 (0.05–1.10) | 0.07 | |
| Antidepressant | 1.88 (0.88–4.02) | 0.10 | |